0001209191-23-043990.txt : 20230801
0001209191-23-043990.hdr.sgml : 20230801
20230801163054
ACCESSION NUMBER: 0001209191-23-043990
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230728
FILED AS OF DATE: 20230801
DATE AS OF CHANGE: 20230801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moran Kevin Patrick
CENTRAL INDEX KEY: 0001806596
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34186
FILM NUMBER: 231132204
MAIL ADDRESS:
STREET 1: C/O VANDA PHARMACEUTICALS INC.
STREET 2: 2200 PENNSYLVANIA AVENUE, SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001347178
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030491827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
BUSINESS PHONE: 202-734-3400
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-28
0
0001347178
Vanda Pharmaceuticals Inc.
VNDA
0001806596
Moran Kevin Patrick
2200 PENNSYLVANIA AVENUE NW
SUITE 300E
WASHINGTON
DC
20037
0
1
0
0
SVP, CFO & Treasurer
0
Common Stock
2023-07-28
4
S
0
412
6.30
D
122514
D
Common Stock
2023-07-28
4
S
0
1800
6.305
D
120714
D
Common Stock
635
I
By Wife
Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
/s/ Kevin Patrick Moran
2023-08-01